Neurodisorders 2019 | Neurology Conferences 2020 | Neurology Congress 2020 | Neuroscience Conferences |Japan| Global Events

Theme: Neurology and Neurodisorders: Unravel the Intriguing Conception

Neurodisorders Congress 2019

Renowned Speakers

Manjula Ricciardi
Northland District Health Board
New Zealand

Malcolm R Hooper
Oxymed, Australia
Australia

Adam Mate
RMIT University (Intellectual Disability)
Australia

Tajjallah Bibi Shamim Khan
SEND Coordinator at Al Maaref Private School
United Arab Emirates

Ghulam Rasool Mashori
University of Medical & Health Sciences for Women
Pakistan

John M Baumann
University of Massachusetts
USA

Tran Thi Hanh
Can Tho Medical College
Vietnam

Dr Mohammed Alobaidi
Mental Health at the Ibb University
Yemen

Dr. Tamara C. McGill-Carter
Gary and a Masterâ€™s of Arts degree from the Chicago School
USA

Neurodisorders Congress 2019

About Conference

Conference Series organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.

With the success and overwhelming response of our previous conferences, Conference Series LLC Ltd is well pleased to announce “26th World Congress on Neurology and Neurodisorders” scheduled during October 30-31, 2019 at Tokyo, Japan. It is the leading meeting dedicated to Neurologists, Researchers, and Academic scientists with the theme “Neurology and Neurodisorders: Unravel the Intriguing Conception”

It is a platform that provides an ideal combination of excellent science, an open atmosphere and allowing attendees and speakers to easily focus on the academic exchange of ideas and authoritative views which covers the entire spectrum of research in Neurosciences.

Why attend?

With members from around the world focused on learning about Neurology and its disorders; this is your best opportunity to reach the largest assemblage of participants from the Neurology sector. It will provide exposure to the on-going researches in the Neuroscience and Neurology labs. Will give opportunities to the companies to showcase their products and have face to face meetings with scientists increasing their business opportunities. It also gives companies to know about their market competitors.

We endeavor to make 26th World Congress on Neurology and Neurodisorders a success, with your support and high-quality talks from Neurological committees. We assure you that you will experience world class facilities and hospitality throughout the conference session.

Presentations, information distribution, meet with current and potential scientists, make a splash with new ways of treatment & care, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in neurology are hallmarks of this conference.

Conference Highlights:

Gathering of World famous Neurologists and Researchers, Psychiatrist, etc.
Discussion of advanced technologies used in the prevention of the Neurodegenerative Disorders (Amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease), Mental Health, Epilepsy, Dementia, Psychology, etc.
New drugs designed to get cure from Neurodegenerative Disorders, and its Therapeutic uses, Workshops, etc.

Who should attend?

Neuroscientist
Neuroanatomist
Neurobiologist
Neurochemist
Neurological Surgeon
Neurologist
Neuropathologist
Neuropharmacologist
Neurophysiologist
Neuropsychologist
Neuroradiologist
Biological Psychologist
Psychiatrist
Neuroscience Nurse
Psychophysicist
Professors
Students
Neuro drug Manufacturers

Benefits of attending:

Networking Opportunities, Grow Your Professional Network
Build Your Knowledge Base
Expand Your Resources
Meet Experts & Influencers Face to Face
Learning In a New Space
Break Out of Your Comfort Zone
New Tips & Tactics
Greater Focus
The Serendipity of the Random Workshop

After a successful conference in 2018, ConferenceSeries llc Ltd is very delighted to invite you all to the "26th World Congress on Neurology and Neurodisorders" (Neurodisorders Congress 2019) scheduled on October 30-31, 2019 at Tokyo, Japan.. We are progressively working for the initiation of a new world, perspectives and views in the field of Neurology and Neurosciences. ConferenceSeries llc Ltd is providing a great platform for thousands of neurologists meet, learn, share and exchange views. We are concentrating on the view that everyone should gain from the conference. So, we are organizing plenary sessions, poster exhibitions and section programs, workshops at the conference.

Neurodisorders Congress 2019 is supported by related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Neurosciences and in the field of Neurological Disorders.

Neurodisorders Congress 2019 will be a great event where experts from universities, top Neuroscience associations, research centers and from the societies and universities related to Neurology gather and share their insights. So, all are wholeheartedly invited to be a part of this conference.

2019 Highlights:

150+ Participation (70% Industry: 30% Academia)
5+ Keynote Speakers
30+ Plenary Speakers
3+ Exhibitors
20+ Innovative Educational Sessions
B2B Meetings

Exhibition:

Why exhibit:

Make sales
Debut new products
Profile your brand
Meet new business partners and suppliers
Develop key relationships
Educate healthcare, Neurology and Neuroscience institutions and academia

Why you should attend:

Take part in the energizing occasion arrange, with round tables, boards, exhibits, seed organizing, and numerous gathering tracks.
Offer encounters, bits of knowledge and procedures in intuitively shared round tables.
Hear more points of view in one place – from extensive medium and little associations from Neurology and Neuroscience and the scholarly community.
See how to build up the correct plan and conveyance system with a solid logical, clinical and business outlook.
Find the most recent advancements in Neurosciences.

Session:1 Neurology

Neurology is a medicinal claim to fame managing disarranges and sicknesses of the sensory or nervous system, It deals with the diagnosis and treatment of all categories of disease and disorders involving the central and peripheral nervous system, including their covers, veins, and all effector tissue, for example, muscle, Also regards the neurological conditions like Alzheimer's ailment, seizures, stroke, loss of motion, trance-like state, epilepsy, meningitis, encephalitis, numerous sclerosis, herpes simplex infection 2, amnesia, Parkinson's illness, paraplegia, hearing misfortune, and different diseases and tumors of the sensory system.

12th Global Neurologists Meeting on Neurology and Neurosurgery, September 21-22, 2018 Singapore| 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 Berlin, Germany| 30th World Psychiatrists and Psychologists Meet, October 01-02, 2018 Osaka, Japan | 3rd International conference on Neuroscience, Neuroradiology & Imaging, October 03-04, 2018 Osaka, Japan| 8th International Congress on Stroke and Brain Hemorrhage, September 20-21, 2018 Prague, Czech Republic| World Brain Congress, December 5-7, 2018 Dubai, UAE| 21st World Congress on Neurology and Therapeutics, March 15-17, 2018 London, UK| 4th Global Experts Meeting on Parkinson’s & Movement Disorders, May 14-15, 2018 Singapore| 25th World Congress on Neurology and Neurodisorders, July 16-17, 2018 Melbourne, Australia| 11^th FENS forum of Neuroscience , July 07-11, 2018, Berlin, Germany | Neurological Disorders Summit , July 06-08,2017, San Francisco, CA , USA| Medical , Medicine and Health sciences, July 08-09 2017, Bali , Indonesia | World congress on Neurology, Sep 16-21 2017, Kyoto, Japan | Congress of European academy of Neurology , June 24-27 2017, Amsterdam , The Netherlands | Australasian Neuroscience Nurses Association (ANNA), Neuroscience Research Australia (NORD) , Australasian Neuroscience Society, Applied Neuroscience Society Of Australasia , Singapore Neuroscience Association (SNA).

Session:2 Central Nervous System

The central nervous system (CNS) is made up of the brain, the spinal cord, and the optic nerves. The central nervous system controls thought processes, guides movement, and registers sensations throughout the body.

Fast facts on the central nervous system
The brain is the most complex organ in the body and uses 20% of the total oxygen we breathe in.
The CNS is often divided into white and gray matter.
The brain consists of an estimated 100 billion neurons, with each connected to thousands more.
CNS support cells, called glial cells, outnumber neurons 10 to 1.
The brain can be divided into four lobes: temporal, parietal, occipital and frontal.
Circuits within the spinal cord are capable of controlling motor coordination without input from the brain.
The brain makes up around 2% of a human's entire weight.

Session:3 Neurosurgery

Neurosurgery or neurological surgery is the medical specialty focused on the prevention, diagnosis, and rehabilitation of disorders which affect any part of the nervous system such as the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. They help in the diagnosis of intracerebral hemorrhage.

Session:4 Neuroimmunology

This term alludes to the interdisciplinary field blending neurology, immunology, and parts of neuroscience. It is a logical and clinical area. Experimentally, Neuroimmunology attempts to comprehend the bidirectional connections between the nervous and immune systems, and their suggestions to sicknesses. Clinically, various “classical” neuroimmune diseases (e.g., multiple sclerosis-MS) and recently more diseases are being recognized for their influence by both the nervous and immune systems, including cancer and coronary heart disease. The natural underpinnings of neuroimmunology incorporate the plummeting pathways from the mind to the resistant framework, showed by innervation of lymph hubs, impacts of pressure hormones on insusceptibility, and the nearness of neurotransmitter receptors on invulnerable cells.

Session:5 Neurorehabilitation

Neurorehabilitation intercessions have detonated since the year 2000, in parallel with a move in the worldview of neurologic care. In the mid-twentieth century, we got some distance from the supposition that the impact of mental damage, for example, a stroke on capacity, movement, and cooperation is perpetual and turned out to be progressively mindful of the cerebrum's regenerative potential, and additionally unique cerebrum rearrangement, months and even numerous years after the fact. Neurorehabilitation scientists pushed for translational research to define the permissive conditions under which optimal brain change and recovery occurs,

Clearly requiring controlled.
Intensive stimulation of impaired brain networks

Session:6 Neuropsychiatry

Neuropsychiatry is an integrative, collaborative discipline that arrangements with the psychiatric aspects of neurological disorders. In science, neuropsychiatry supports the field of neuroscience and is utilized to better comprehend the neurological underpinnings of the psychiatric and neurologic diseases and to analyze the treatment and care of people with neurological conditions, especially those that influence conduct.

Session:7 Neurochemistry

Neurochemistry alludes to the synthetic procedures that happen in the cerebrum and sensory system. The way that one can read this content, recollect what has been perused, and even inhale amid the whole time that these occasions happen depends on the stunning science that happens in the human mind and the nerve cells with which it imparts.

There are two broad categories of chemistry in nerve systems that are important. The first is the chemistry that generates electrical signals which propagate along with nerve cells. The key chemicals involved in these signals are sodium and potassium ions. To see how they give rise to a signal, one must first look at a nerve cell that is at rest.

Session:8 Neuro Cardiology & Strokes

Neurocardiology alludes to the pathophysiological interactions of the cardiovascular and sensory systems. It is the investigation of neurological, neurophysiological and neuroanatomical parts of cardiology including the neurological starting points of cardiovascular issue. The neurocardiac pivot connects the cardiovascular and sensory systems to physiological issues, for example, stroke, epilepsy, and arrhythmias. Clinical issues in Neurocardiology include neurogenic stress cardiomyopathy, cardiovascular findings in patients with primary neurological disease, neurologic sequelae of cardiac and thoracic surgery and cardiac interventions and hypoxic-ischemic brain injury.

A stroke is a "brain attack". It can happen to anyone at any time. It occurs when blood flow to an area of the brain is cut off. When this happens, brain cells are deprived of oxygen and begin to die. When brain cells die during a stroke, abilities controlled by that area of the brain such as memory and muscle control are lost.

Session:9 Neuroendocrinology

Neuroendocrinology is the investigation of communications between the nervous and endocrine systems. The field of neuroendocrinology has extended from its unique spotlight on the control of pituitary hormone emission by the hypothalamus to include different equal connections between the focal sensory system (CNS) and endocrine frameworks in the control of homeostasis and physiologic reactions to natural jolts. The discipline of neuroendocrinology, extensively characterized, envelops the systems, forms, and physiologic reactions that facilitate and coordinate the interior hormonal milieu.

Session:10 Neuro-ophthalmology

Neuro-ophthalmology is a scholastically situated subspecialty that consolidations the fields of neurology and ophthalmology, regularly managing complex fundamental illnesses that have indications in the visual framework. Neuro-ophthalmologists at first entire a residency in either neurology, neurosurgery, or ophthalmology, at that point, complete a partnership in the reciprocal field. Since demonstrative examinations can be ordinary in patients with the noteworthy neuro-ophthalmic disease, a point by point restorative history and physical exam is fundamental, and neuro-ophthalmologists regularly invest a lot of energy with their patients.

Session:11 Neuro-Oncology

Neuro-oncology is the investigation of brain and spinal cord neoplasms, huge numbers of which are (in any event in the end) exceptionally risky and hazardous. Among the harmful mind diseases, gliomas of the brainstem and pons, glioblastoma multiforme, and high-review (exceedingly anaplastic) astrocytoma are among the worst. In these cases, untreated survival, as a rule, adds up to just a couple of months, and survival with ebb and flow radiation and chemotherapy medicines may expand that time from around multi-year to eighteen months, conceivably at least two, contingent upon the patient's condition, resistant capacity, medications utilized, and the particular kind of dangerous cerebrum neoplasm. The medical procedure may now and again be remedial, be that as it may, when in doubt, harmful mind growths have a tendency to recover and rise up out of reduction effortlessly, particularly exceedingly dangerous cases. In such cases, the objective is to extract as a significant part of the mass (tumor cells) and however much of the tumor edge as could reasonably be expected without jeopardizing imperative capacities or other essential subjective capacities.

Session:12 Neurotoxicity of Drug Abuse

Neurotoxicity is considered as a major cause of neurodegenerative disorders. Most drugs of abuse have non-negligible neurotoxic impacts a significant number of which are essentially interceded by a few dopaminergic and glutamatergic neurotransmitter frameworks. Neurotoxicity and formative neurotoxicities are imperative antagonistic wellbeing impacts of several ecological contaminants and word related synthetic substances, regular poisons and pharmaceutical medications.

Session:13 Neuromuscular and Spinal Disorders

Neuromuscular disorders are conditions that affect skeletal muscles, peripheral nerves or neuromuscular junction. Our program treats all forms of neuromuscular disorders, including Amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT) Guillain-Barre syndrome (GBS), Chronic inflammatory demyelinating polyneuropathy (CIDP).

The spinal disorders are the results of infection, injuries, tumors, Ankylosing spondylitis, scoliosis, spinal stenosis, and herniated disks. When the structure of bone changes then it causes pain due to the pressure on the spinal cord and the nervous system. These disorders can be diagnosed by computed tomography, discography, electromyography, MRI ETC. It causes the skeletal hyperostosis, fracture of the thoracic and lumbar spine, etc.

Session:14 Depression, Anxiety & Schizophrenia

Depression, in psychology, a mood or emotional state that is marked by feelings of low self-worth or guilt and a reduced ability to enjoy life. A person who is depressed usually experiences several of the following symptoms: feelings of sadness, hopelessness, or pessimism; lowered self-esteem and heightened self-depreciation; a decrease or loss of ability to take pleasure in ordinary activities; reduced energy and vitality; slowness of thought or action; loss of appetite; and disturbed sleep or insomnia.

Anxiety is an emotion characterized by feelings of tension, worried thoughts and physical changes like increased blood pressure. People with anxiety disorders usually have recurring intrusive thoughts or concerns. They may avoid certain situations out of worry. They may also have physical symptoms such as sweating, trembling, dizziness or a rapid heartbeat.

Schizophrenia, any of a gathering of extreme mental issue that has in like manner such indications as fantasies, hallucinations, blunted feelings, cluttered reasoning, and a withdrawal from the real world. Schizophrenics show a wide cluster of side effects, yet five principal kinds of schizophrenia, varying in their particular symptomatology as takes after, are perceived by a few specialists.

Session:15 Alzheimer's, Dementia and Epilepsy

Alzheimer disease, the degenerative brain disorder that develops in mid-to-late adulthood. It results in a progressive and irreversible decline in memory and a deterioration of various other cognitive abilities. The disease is characterized by the destruction of nerve cells and neural connections in the cerebral cortex of the brain and by a significant loss of brain mass.

Dementia is a broad description which includes many different symptoms, including memory loss, word-finding difficulties, impaired judgment, and problems with day-to-day activities, which are caused by injury or loss of brain cells (neurons). Mild Cognitive Impairment is an intermediate stage between the normal and serious decline of dementia. Problems arise in thinking, language, judgment, etc.

Epilepsy is a condition in which a person has repetitive seizures. A seizure is characterized as an abnormal, disorderly discharging of the brain's nerve cells, resulting in a temporary disturbance of motor, sensory, or mental function. There are numerous sorts of seizures, depending principally on what part of the brain is involved. The term epilepsy says nothing about the type of seizure or cause of the seizure, only that the seizures happen again and again. A stricter definition of the term requires that the seizures have no known underlying cause. This may also be called primary or idiopathic epilepsy.

Session:16 Progress in Neurology

Future research bearings in brain issue
Human echolocation
Synaptic Pruning
Late medication advancement and conveyance frameworks
Novel Therapeutic Targets
Pre-Clinical Translational Modeling in Neurodegeneration
Neural Cell Transplantation
Recent Neurosurgical Interventional Procedures

Session: 17 Mental Health and Substance Abuse

Mental illness is regular among a population suffering from substance abuse and addiction. The relationship is strong to the point that numerous individuals trust the medications assume a causative part in the improvement of the dysfunctional behavior. In many cases, this isn't the situation. In the United States, roughly 8.9 million individuals have both psychological well-being and a substance mishandle issue.

The Substance Abuse and Mental Health Administration (SAMHSA) discloses to us that, of these individuals battling with the double issue, the larger part—55.8%—don't get any treatment for either scatter. An unimportant 7.4% get treatment for the two issues.

Session: 18 Meditations and Yoga

Brain researchers have detected improvements in cognition and emotional well-being associated with meditation and yoga, as well as differences in how meditation and prayer affect the brains of those who believe in God and those who do not.

At a 28 September Neuroscience & Society event cosponsored by AAAS and the Dana Foundation, neuroscientist Sara Lazar said that not only were the brain images in a study of people who meditated different from those who did not, other research showed that certain changes in performance such as improved scores on the Graduate Record Exam (GRE) occurred in controlled experiments involving mindfulness training.

Session:19 Neurological Disorders, Autism Spectrum Disorder, and Bipolar Disorders

Neurological disorders are diseases of the brain, spine and the nerves that connect them. In recognizing the signs and symptoms of neurological problems, it is first important to distinguish the various types of neurological disorders.

Autism spectrum disorders are pervasive developmental disabilities in which the core impairments have a profound influence on children’s development. A relative or total absence of reciprocal social interactive skills is the primary symptom seen in young children with autism spectrum disorders. Unlike typically developing toddlers, who make almost nonstop bids for parental attention, these children make less frequent eye contact and direct fewer facial expressions toward their parents.

Bipolar, or hyper depressive issue, is a disposition issue that causes radical enthusiastic changes and emotional episodes, from hyper highs to depressive lows. The greater part of bipolar people encounters substituting scenes of madness and misery.

Session 20 Multiple sclerosis

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).

In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

Signs and symptoms of MS vary widely and depend on the amount of nerve damage and which nerves are affected. Some people with severe MS may lose the ability to walk independently or at all, while others may experience long periods of remission without any new symptoms.

There's no cure for multiple sclerosis. However, treatments can help speed recovery from attacks, modify the course of the disease and manage symptoms.

Numbness or weakness in one or more limbs that typically occurs on one side of your body at a time, or the legs and trunk
Partial or complete loss of vision, usually in one eye at a time, often with pain during eye movement
Prolonged double vision
Tingling or pain in parts of your body
Electric-shock sensations that occur with certain neck movements, especially bending the neck forward (Lhermitte sign)
Tremor, lack of coordination or unsteady gait
Slurred speech
Fatigue
Dizziness
Problems with bowel and bladder function

Market Analysis

Summary of 26th World Congress on Neurology and Neurodisorders:

Neurodisorders Congress 2019 cordially invites you all to be a part of this conference which is mainly focusing on latest advancements emerging in the field of Neurosciences. ConferenceSeries Ltd is providing a great platform for thousands of Neurologists meet, learn, share and exchange views.

Global neuroscience industry demand was worth USD 24.09 Billion in 2013 and is anticipated to reach above USD 30.80 billion by 2020. Rising investment in R&D resulting in the development of numerous products in the neuroinformatics coupled with adequate funding from the government are key factors that drive growth in this market.

Neuro-informatics involves designing and developing efficient tools and algorithms that can augment the performance of structural and functional mapping. Global Neuroscience market is expected to grow at CAGR of 2.9% over the next seven years.

As per the BCC report, the global market for neurological disease treatment and medication was worth $12.6 billion in 2006 and will reach $14 billion by 2007. At a compound annual growth rate (CAGR) of 11.6%, the global market will be worth almost $24.3 billion by 2012.

Drugs for multiple sclerosis, Alzheimer's disease, and Parkinson's disease control approximately 99% of the total market share. Medications for multiple sclerosis are just over 35% greater than the market share of medication for Alzheimer's disease, despite the fact that there are far fewer patients with MS. As AD drugs become more prevalent, the shares of the market could change dramatically.

Report Scope

This report contains:

An analysis of the trends in drug discovery and development for the neurodegenerative disorders
An overview of the global neurological disorders treatment market which provides definitions and a structure for the industry
Provides details for the treatment markets of specific diseases such as Alzheimer's, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, muscular dystrophy, and other, rarer neurological disorders
Offers a detailed analysis of patents as well as important technological developments
A review of government regulations
Profiles the most important companies in the industry today.

Why Tokyo??

Tourist attraction:

The Imperial Palace, Ginza District, Asakusa, and the SensÅ-Ji Temple, National Museum of Nature and Science, Ueno Park and Zoo, Tokyo National Museum, National Museum of Western Art, The Meiji Shrine, The Miraikan and Edo-Tokyo Museums, The Tokyo Skytree, The National Art Center, The Kabuki-za Theatre.

Conference Highlights

Neurology
Central Nervous System
Neurosurgery
Neuroimmunology
Neurorehabilitation
Neuropsychiatry
Neurochemistry
Neuro Cardiology & Strokes
Neuroendocrinology
Neuro-Ophthalmology
Neuro-Oncology
Neurotoxicity of Drug Abuse
Neuromuscular and Spinal Disorders
Depression, Anxiety & Schizophrenia
Alzheimer’s, Dementia and Epilepsy
Progress in Neurology
Mental Health and Substance Abuse
Meditation and Yoga
Neurological Disorders, Autism Spectrum Disorder, and Bipolar Disorders

Why attend???

Meet Your Target Market With members from around the world focused on learning about the latest innovations in screening and treatments for neurological disorders; this is your single best opportunity to reach the largest assemblage of participants from the Universities, Neurology research centers and hospitals and conduct demonstrations of new screening instruments, distribute information about novel agents and strategies, meet with highly affiliated speakers, showing of clinical trials as well as advancements in new neurological therapies, current methods and controversies in psychic therapy and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques for screening as well as for treatment, and the newest updates in Neurological disorders and treatments are hallmarks of this conference.

Target Audience:

Industry - 21%
Student - 17%
Academia - 42%
Government - 11%
Others - 9%

Major Neuroscience Societies and Associations in Tokyo

Japan Society of Psychiatry and Neurology
Japanese mental disorder prevention society
Japanese Society of General Hospital Psychiatry
Association of Japanese Clinical Psychology
Japanese psychiatry diagnosis society
The Japanese Society of Psychiatry and Neurology

Major Neuroscience Societies and Associations in Japan

Japan Society of Psychiatry and Neurology
Japanese mental disorder prevention society
Japanese Society of General Hospital Psychiatry
Association of Japanese Clinical Psychology
Japanese psychiatry diagnosis society
The Japanese Society of Psychiatry and Neurology

Societies Associated with Neurological Research

Mental health Association in Maryland
Society for Mental Health Research
American Academy of Child and Adolescent Psychiatry
Australian Clinical Psychology Association
American Association of Neurological Surgeons
World Psychiatry Association
American Psychiatric Association
European Psychiatric Association

Members Associated with Neurological Research

Neurologists
Psychologists
Neurosurgeons
Neuro Researchers
Students
Neuro Engineers

Top Neuroscience Universities in Japan

Aino University
Osaka Kawasaki Rehabilitation University
Hagoromo International University
Osaka University of Human Sciences
Hannan University
Soai University
Heian Jogakuin-St. Agnes'-University
Tokiwakai Gakuen University
Kansai Medical University
Osaka University
Kinki University
Okinawa Institute of Science and Technology
Kwansei Gakuin University, Osaka-Umeda
Keio University
Morinomiya University of Medical Sciences
Nagoya University

Top Neurology Universities in Globe

Leiden University
Keele University
Plymouth University
University of Toledo
University of Sheffield
University of Birmingham

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 30-31, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View